EN DE

HUNAN RESUN Co (001218) Fair Value & Analysis

Consumer Defensive · CN · Market cap 3.3B CNY

HR HUNAN RESUN Co 001218 · SHE
Price¥24.48
Fair Value¥26.05
Upside+6.4%
Quality68/100
Watch HUNAN RESUN Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 4.0% net margin
generates free cash flow
2.19% dividend yield
Ranks above peers (9/13)
Narrow moat 37/100
Evidence: High Range ¥19.54 – ¥32.56 Share as image

Fair value as of: Jul 21, 2026

From 24 valuation models · updated 20 days ago

Share price +1.7% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • Our model range runs from ¥19.54 (bear) to ¥32.56 (bull), base ¥26.05. The closer the price sits to the lower half, the larger the margin of safety.
  • Quality 68/100 (solid quality) with high evidence: the data supports the verdict.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥40.90 ¥12.47 Fair Value ¥26.05 Oct 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.

How to read this chart

58‑month range ¥12.47 – ¥40.90 · fair‑value band ¥19.54 – ¥32.56 · the ¥24.48 price screens below the ¥26.05 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

HUNAN RESUN Co (001218) currently trades at ¥24.48, while our model-based Fair Value estimate is ¥26.05, implying the stock looks roughly 6.4% fairly valued today. The Quality Score stands at 68/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, HUNAN RESUN Co generated revenue of 5.3B CNY at a net margin of 4.0%. Revenue grew 33.7% year over year. It earns a return on equity of 9.1%. The balance sheet holds a net cash position of 661M CNY. Fundamentals as of Jul 21, 2026

Our scenario range runs from ¥19.54 (bear case) to ¥32.56 (bull case); at ¥24.48, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 16% below its 52-week high and 48% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at 6%, 001218 screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income ¥14.31 ¥14.93 ¥15.60 76
Growth DCF ¥22.49 ¥37.12 ¥61.93 72
Growth-Adj P/E ¥18.73 ¥26.76 ¥34.78 68
All 24 models by family
DCF Models
FCF DCF ¥22.92 ¥38.88 ¥70.27 38
Owner Earnings ¥22.43 ¥38.90 ¥68.50 31
5Y Revenue Exit ¥19.04 ¥30.50 ¥46.43 39
5Y EBITDA Exit ¥23.58 ¥40.35 ¥62.20 41
5Y P/E Exit ¥22.87 ¥38.81 ¥57.82 38
10Y Revenue Exit ¥19.74 ¥31.22 ¥49.72 36
10Y EBITDA Exit ¥23.19 ¥38.50 ¥63.30 37
10Y P/E Exit ¥22.72 ¥37.36 ¥59.53 35
Earnings-Based
Graham-Dodd ¥8.44 ¥46.28 ¥64.21 54
Lynch FV ¥12.88 ¥18.40 ¥23.92 50
PEG = 1.0 ¥12.88 ¥18.40 ¥23.92 46
EPV ¥15.88 ¥17.67 ¥19.22 59
Multiples
P/E Multiple ¥19.54 ¥26.05 ¥32.56 63
P/S Multiple ¥15.82 ¥21.09 ¥26.36 58
P/B Multiple ¥15.82 ¥21.09 ¥26.36 55
EV/EBIT ¥22.22 ¥28.13 ¥34.03 53
EV/EBITDA ¥25.16 ¥32.04 ¥38.92 54
EV/Revenue ¥17.15 ¥22.57 ¥27.99 43
Asset-Based
NCAV (Graham) ¥8.99 ¥12.05 ¥17.98 50
Growth DCF
Growth DCF ¥22.49 ¥37.12 ¥61.93 72
Rev-Margin DCF ¥19.04 ¥30.15 ¥45.33 67
Economic Profit
Residual Income ¥14.31 ¥14.93 ¥15.60 76
ROIC Compounder ¥15.88 ¥17.67 ¥20.94 67
Growth Earnings
Growth-Adj P/E ¥18.73 ¥26.76 ¥34.78 68

Widest divergence: DCF Models (¥38.50) versus Asset-Based (¥12.05). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) 5.3B CNY
Revenue growth (YoY) +33.7%
Net margin 4.0%
Return on equity 9.1%
Free cash flow 183M CNY FY2025
P/E ratio 15.2
More key figures
Operating margin 6.7%
EPS (TTM) ¥1.65
Dividend yield 2.2%
EPS growth (YoY) +186%
Net cash 661M CNY FY2024

Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 68/100

Of which business quality 68 · Market factors (momentum, volatility) 63

Profitability 46
Margins and returns on capital today
Quality Growth 68
Are margins and returns improving?
Cashflow 48
Earnings quality: real cash, not paper profit
Fin. Strength 92
Balance sheet, leverage, solvency risk
Investment 84
Disciplined investing over empire-building
Low Volatility 75
Calm price path (market factor)
Momentum 54
Price trend over the last 3–12 months (market factor)
52W Momentum 66
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

HUNAN RESUN Co., Ltd. engages in the research and development, production, and sale of surfactants and detergents in China.

Full company description

HUNAN RESUN Co., Ltd. engages in the research and development, production, and sale of surfactants and detergents in China. The company's products include sodium/ammonium lauryl ether sulfate, sodium/ammonium lauryl sulfate, alkyl benzene sulphonate, sodium a-olefin sulfonate, amino acid-based surfactant, alkyl glucoside, amine derivatives and other products, including cocoamidopropyl amine oxide, cocodiethanol amide, and cocomonoethanol amide. Its products are used in personal and home care, construction, oil, agriculture, and PVC and ACR fields. The company also exports its products to Southeast Asia, the Middle East, Africa, the United States, and internaionally. HUNAN RESUN Co., Ltd. was founded in 1956 and is headquartered in Changsha, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

HUNAN RESUN Co reported revenue of ¥5.0B in FY2025 versus ¥2.7B in FY2021, a compound +16.0%/yr. Reported net income was ¥161M in FY2025, compounding −2.5%/yr from FY2021.

Growth Quality 77/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
5.0B CNY
Latest YoY
+36.6%
Avg. growth/yr (3Y)
+17.8%
Avg. growth/yr (5Y)
+16.0%
Avg. growth/yr (12Y)
+12.4%
Revenue +16.0%/yr
FY21 ¥2.7B
FY22 ¥3.0B
FY23 ¥3.2B
FY24 ¥3.6B
FY25 ¥5.0B
Net income −2.5%/yr
FY21 ¥179M
FY22 ¥120M
FY23 ¥136M
FY24 ¥109M
FY25 ¥161M

Watch 001218: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "HUNAN RESUN Co Fair Value". https://www.fairvalue-calculator.com/stock/001218

Peer Group

Household & Personal Products · 244 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 68 · Top 25%
Fair Value upside +6% · Above median
Return on equity (TTM) 9% · Above median
Return on assets 5% · Above median
Net margin (TTM) 4% · Below median
Operating margin (TTM) 7% · Below median
Revenue growth 34% · Top 25%
Dividend yield (TTM) 2.2% · Below median

Valuation Multiples vs Household & Personal Products median · lower = cheaper

P/E (TTM) 15.2× · Cheaper than median
P/B 1.40× · Cheaper than median
P/S (TTM) 0.61× · Cheaper than median
P/FCF 2.7× · Pricier than median
EV/EBITDA 8.3× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 42 · sector 28
FUTURE 100 · sector 4
PAST 36 · sector 26
HEALTH 0 · sector 98
DIVIDEND 44 · sector 50

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).

Stock Price Fair Value vs Fair Value
The Procter & Gamble Company PG $146.80 $108.16 -26%
Unilever PLC ULN 1,080 MXN 1,273 MXN +18%
Hindustan Unilever Limited HINDUNILVR ₹2,144 ₹1,000 -53%
Essity AB ESSITYA kr 279.00 kr 250.02 -10%
Godrej Consumer Products Limited GODREJCP ₹1,088 ₹367.64 -66%
Marico Limited MARICO ₹846.75 ₹233.05 -72%
APR Co 278470 375,000 KRW 151,222 KRW -60%
Dabur India Limited DABUR ₹429.45 ₹181.60 -58%
Kimberly-Clark de México, S. A. B. de C. V., KIMBERA 38.07 MXN 50.09 MXN +32%
PT Unilever Indonesia Tbk UNVR 1,730 IDR 1,934 IDR +12%

Compare HUNAN RESUN Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is HUNAN RESUN Co (001218) overvalued or undervalued?
As of Jul 21, 2026, our model estimates a fair value of ¥26.05 versus a price of ¥24.48, about +6% (fairly valued).
What is the fair value of 001218?
Our model-based fair value for HUNAN RESUN Co is ¥26.05 (as of Jul 21, 2026), built from audited fundamentals. The current price is ¥24.48.
What is the quality score of 001218?
HUNAN RESUN Co has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of HUNAN RESUN Co (001218)?
HUNAN RESUN Co reported trailing-twelve-month revenue of about 5.3B CNY (latest available figure, as of Jul 21, 2026).
What is the net profit margin of 001218?
The net profit margin of HUNAN RESUN Co is about 4.0%, meaning it keeps roughly 4.0% of revenue as net income. Based on the latest reported figures.
Does HUNAN RESUN Co pay a dividend?
HUNAN RESUN Co currently shows a dividend yield of about 2.19% relative to its recent price (as of Jul 21, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track HUNAN RESUN Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.